Pharmacologic Treatment of Refractory ICU Delirium
Back to course
Video Transcription
Video Summary
Asset Subtitle
Neuroscience, Pharmacology, 2022
Asset Caption
Delirium is common in many critically ill patients and is associated with increased duration of mechanical ventilation, duration of ICU and hospital lengths of stay, and long-term cognitive impairment. Patients may be refractory to multiple standard treatment modalities requiring alterative pharmacologic and nonpharmacologic treatment regimens. There are many research gaps in this area, and this session will help provide insight into multifaceted management strategies for refractory ICU delirium.
Meta Tag
Content Type Presentation
Knowledge Area Neuroscience
Knowledge Area Pharmacology
Knowledge Level Intermediate
Knowledge Level Advanced
Learning Pathway Delirium and Sedation Managment
Membership Level Select
Tag Delirium
Tag Pharmacology
Year 2022
Keywords
pharmacologic treatment
refractory ICU delirium
PADIS guidelines
dexmedetomidine
non-pharmacological therapy

   

   
 
Society of Critical Care Medicine

500 Midway Drive
Mount Prospect, IL 60056 USA

Phone: +1 847 827-6888
Fax: +1 847 439-7226
Email: support@sccm.org


Contact Us

About SCCM

Newsroom

Advertising & Sponsorship

DONATE


MySCCM

LearnICU

Patients & Families

Surviving Sepsis Campaign

Critical Care Societies Collaborative


kisspng-facebook-social-media-computer-icons-linkedin-soci-gray-5ac493cf1c2975.7867418415228323351154  - KW Symphony    Gray twitter 3 icon - Free gray social icons    Gray linkedin 3 icon - Free gray site logo icons    Gray instagram icon - Free gray social icons    YouTube Icon Gray Box - HONOR VETERANS NOW

GET OUR NEWSLETTER






© Society of Critical Care Medicine. All rights reserved.   |    Privacy Statement    |    Terms & Conditions
The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.



Android App Download IOS App Download Powered By